Foravirumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | rabies virus glycoprotein |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 944548-38-3 |
| ATC code | None |
| UNII | 377VY97V7S |
| Chemical data | |
| Formula | C6400H9914N1718O1998S44 |
| Mol. mass | 144.3 kDa |
| |
|
Foravirumab is a monoclonal antibody for the prophylaxis of rabies.[1]
References
- ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
|
||||||||||||||||||||||||||||||||||||||||
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
| This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
